Post partum

In patients with moderate to severe MS, restart immunotherapy 2 weeks post partum, to minimise the risk of relapse. Immediately restarting immunotherapy (eg the day after giving birth) is not advised, in case the patient has a postpartum infection or wound infection (eg after a Caesarean section).

Evidence for the safety of breastfeeding during immunotherapy is lacking—seek expert advice.

In patients with mild MS, breastfeeding may be possible—seek expert advice.